Free Trial

Ramaphosa Looks to Bolster Credibility Further With Dismissal of Health Minister

SOUTH AFRICA
  • Local media very much focused on yesterday's Zuma verdict, with the former President sentenced to a 15-month jail term for contempt, having defied a court order to testify at the ongoing graft inquiry.
  • Ongoing political wrangling continues, with BusinessDay today reporting that Ramaphosa is to dismiss Zweli Mkhize - the health minister - in response to their involvment in a multi-million rand tenders scandal. The move is seen bolstering Ramaphosa's credibility and may win more support for his anti-graft reform agenda.
  • Gauteng's struggles with the more transmissible Delta variant continue, with the mutation now dominant across the region, according to the National Institute for Communicable diseases.
  • Ramaphosa's COVID response has come under fire from the SA Medical Association, who stated that the decision to up activity restrictions should have been considered at least two weeks ago, warning that the delay is causing mistrust in the government.
  • This morning's money supply release showed a modest slowdown in M3, edging lower to 1.82% from 2.02%. Private sector credit contracted, but at a slower pace of -0.42% vs. Exp. -0.95%. Trade balance and monthly budget balance data crosses later today, with May expected at a surplus of ZAR 49.6bln. Data crosses at 1300BST.
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.